Alternatively, low glutamine availability—which is associated with less vascularized tumors such as the larger DU-145 tumors in this report (Fig. 4)—has been shown to decrease ASCT2 expression in liver62 and gastric63 cancer cell lines. Here, SLC1A5 is linked to cancer.